A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
7h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN ...
CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.
Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback